Highlights of January 2019Aurobindo to buy 7 oncology injectables from Spectrum Pharma in US$300 Million deal.Glenmark inks pact with South Korea...
Read MoreHighlights of December 2018Lupin partners with AbbVie to develop, commercialize novel oncology drug with US$30 Million upfront.Prestige BioPharma...
Read MoreHighlights of November 2018Cipla‘s InvaGen Pharma to acquire US-based Avenue Therapeutics (Fortress Bio company) for up to US$ 215 Millio...
Read MoreHighlights of October 2018Zydus to buy Heinz’s India business, including Complan, for US$ 633 Million.Quest Diagnostics has agreed to sell off ...
Read MoreHighlights for September 2018Aurobindo Pharma buys Sandoz's US business in US$900 Million deal.Olon S.p.A., a world leading Active Pharmaceutical...
Read MoreHighlights for August 2018Glenmark partners with Harbour BioMed to develop, manufacture and commercialize the former’s novel oncology molecule ...
Read MoreHighlights for July 2018Cipla through its South African subsidiary, Medpro South Africa, has acquired 100% stake in Mirren Pty for US$33 Million....
Read MoreHighlights for June 2018Cipla partners with Eli Lilly to market Lilly’s insulin glargine injection, Basaglar, in India.Lupin has tied up with J...
Read MoreHighlights for May 2018Aurobindo Pharma launches $1.6B bid to buy Novartis generics unit which includes an array of dermatology brands, prod...
Read MoreHighlights for April 2018Glenmark enters licensing pact with Helsinn for its chemo-induced nausea drug.Chrys Capital-led consortium set to buy 10...
Read More